Changes in energy, sexual health, strength, mood, or body composition can make men wonder whether low testosterone is part of the problem.
Sometimes it is.
Brazos Vitality & Precision Wellness provides testosterone evaluation in Richwood, Texas for men who want a clearer understanding of their symptoms, testosterone levels, and whether testosterone replacement therapy may be appropriate.
TRT should not begin with the assumption that every man with fatigue or a low lab result needs testosterone. Appropriate evaluation looks at symptoms, repeated testosterone testing when indicated, health history, fertility goals, possible causes of low testosterone, and the potential benefits and risks of therapy.
It is easy to see a testosterone result marked “low” and assume the next step is TRT. The diagnosis is more involved than that.
The Endocrine Society recommends diagnosing hypogonadism only when a man has symptoms or signs consistent with testosterone deficiency and testosterone levels that are unequivocally and consistently low. It also recommends confirming a low result with a repeat morning fasting testosterone measurement. (Endocrine Society)
That distinction matters because testosterone levels can vary.
They can be affected by the time of day, illness, medications, nutrition, weight, and other factors. Symptoms such as low energy, lower libido, mood changes, and reduced strength can also have causes unrelated to testosterone. A testosterone number can be useful. It should not be interpreted by itself.
Testosterone replacement therapy, commonly called TRT, involves prescribing testosterone to men with appropriately evaluated testosterone deficiency when therapy is clinically appropriate. Testosterone is a hormone involved in male sexual development, sexual function, sperm production, muscle and bone health, and other physiological functions.
FDA-approved testosterone products are used for men with low testosterone associated with certain medical conditions. The FDA currently lists approved formulations that include topical gel, transdermal patches, buccal systems, injections, and oral products depending on the specific medication. (U.S. Food and Drug Administration)
TRT is not intended to be a generic anti-aging strategy or a way to push testosterone as high as possible.
The purpose of evaluation is to determine whether a man’s symptoms and laboratory findings support testosterone deficiency, understand why testosterone may be low, and decide whether replacement therapy is a reasonable option.
Low testosterone can be associated with several symptoms, but none of these symptoms is specific enough to diagnose testosterone deficiency by itself.
A persistent decrease in libido is one of the symptoms that can occur with testosterone deficiency. Low libido can also be influenced by medications, relationship factors, stress, sleep, depression, other health conditions, and additional hormonal factors.
Sexual function concerns may lead a man to investigate testosterone. Testosterone deficiency can contribute to sexual symptoms in some men, but erectile dysfunction has many possible causes and should not automatically be attributed to low testosterone.
Men with testosterone deficiency may report lower energy. Fatigue, however, is one of the least specific symptoms in medicine. Sleep disorders, medications, stress, illness, anemia, nutritional issues, and other conditions may also contribute.
Testosterone plays a role in maintaining muscle and bone. Changes in strength or body composition may be part of a testosterone-related concern, but they can also be affected by age, activity level, nutrition, sleep, weight, illness, and medications.
Some men with testosterone deficiency describe changes in mood or motivation. These symptoms also occur for many reasons unrelated to testosterone, so they require context.
Testosterone and male reproductive function are related, but this is an area where TRT requires particular caution.
External testosterone can suppress the body’s own testosterone production and sperm production. Men who want to preserve fertility should discuss that goal before starting TRT.
The Endocrine Society’s current position is that hypogonadism requires both appropriate symptoms and consistently low, accurately measured testosterone levels. Its July 2026 statement also emphasizes that common symptoms such as low energy, libido, and mood can have many other causes and that reversible contributors should be considered. (Endocrine Society)
Start with an evaluation instead of a conclusion.
Brazos Vitality & Precision Wellness can review your symptoms, health history, and whether testosterone testing or further evaluation may be appropriate.
The evaluation starts with more than a lab panel.
The first step is understanding why testosterone is being considered.
What symptoms are you experiencing?
When did they begin?
Are they persistent?
Are medications, sleep, weight changes, other health conditions, or lifestyle factors relevant?
This gives laboratory testing a reason and context.
The Endocrine Society recommends confirming suspected hypogonadism using repeated morning fasting total testosterone measurements. Its 2026 statement describes at least two early-morning fasting testosterone tests as part of appropriate diagnosis. (Endocrine Society) Timing matters because testosterone levels naturally vary during the day. One isolated result should not automatically determine the diagnosis.
If testosterone is consistently low, additional evaluation can help determine why. The Endocrine Society recommends distinguishing between primary hypogonadism involving the testes and secondary hypogonadism involving the pituitary or hypothalamus, including measurement of LH and FSH when appropriate. (Endocrine Society) The exact additional testing depends on the individual.
Some factors that lower testosterone may be reversible or modifiable. The Endocrine Society notes that obesity, certain medications, illness, and other factors can contribute to low testosterone. Its 2026 statement specifically says weight loss is typically first-line for appropriately diagnosed low testosterone associated with overweight or obesity when no other cause is identified. (Endocrine Society) That is another reason to understand the cause before assuming TRT is the first step.
Men often search for one universal “normal testosterone level.” Real-world interpretation is more nuanced. Reference ranges can vary by laboratory and testing method. Testosterone also changes throughout the day.
The Endocrine Society has highlighted problems with inconsistent assays and recommends accurate, standardized testing whenever possible. (Endocrine Society) A number therefore has to be interpreted alongside:
Symptoms.
The testing method.
The time the sample was collected.
Whether the level was confirmed.
Other relevant laboratory results.
Health history.
Possible causes of testosterone deficiency. The goal should not be to decide that every man below one internet number needs TRT.
The exact Brazos workflow should be confirmed before publication, but the page should reflect an evaluation-first process.
The consultation begins with your symptoms, concerns, goals, and what led you to ask about testosterone. This helps determine whether testosterone evaluation is appropriate and whether other issues also deserve attention.
Health history matters when evaluating both testosterone deficiency and TRT candidacy. Relevant information may include medications, cardiovascular history, prostate history, sleep concerns, fertility plans, previous laboratory results, and other health conditions.
When testosterone deficiency is suspected, testing should be performed under appropriate conditions and low values should generally be confirmed rather than relying on a single result.
A low testosterone level is not the end of the evaluation. Further testing or assessment may be appropriate to determine whether the cause appears to involve the testes, pituitary or hypothalamus, medications, weight-related factors, or another issue.
If the findings support testosterone deficiency, the next conversation is whether testosterone therapy is appropriate for you. That discussion should include expected benefits, limitations, risks, fertility considerations, treatment options, and monitoring.
TRT requires follow-up. The Endocrine Society recommends evaluating men after treatment begins to assess response, adverse effects, and adherence. (Endocrine Society)
TRT may be considered for men with appropriately diagnosed testosterone deficiency when expected benefits outweigh potential risks.
That requires more than simply wanting a higher testosterone number.
The strongest candidate is generally a man with symptoms consistent with testosterone deficiency, repeatedly low testosterone levels measured appropriately, and a clinical evaluation supporting hypogonadism. (Endocrine Society). The cause of low testosterone also matters.
Some men may benefit from addressing contributing factors before or instead of beginning testosterone therapy.
And some men have health or fertility considerations that make TRT inappropriate or require additional evaluation.
Testosterone therapy is not appropriate for every man with a low testosterone result. Endocrine Society guidance recommends against starting TRT in certain circumstances, including men planning fertility in the near term and men with specific prostate, hematologic, cardiovascular, sleep, or thrombotic concerns unless those issues have been appropriately evaluated. (Endocrine Society) That is why a website checklist should never be used to determine eligibility. The individual details matter. A consultation should review the health factors that may affect whether testosterone therapy is appropriate and whether additional evaluation is needed before treatment is considered.
This subject deserves prominent placement because many men do not realize TRT can affect fertility. External testosterone can suppress the hormonal signals that stimulate the testes to produce sperm. For that reason, the Endocrine Society recommends against testosterone therapy in men planning fertility in the near term. (Endocrine Society) If having biological children now or in the future is important to you, that should be discussed before TRT begins. A fertility goal may change the treatment conversation.
TRT may improve symptoms of testosterone deficiency in appropriately selected men, but taking testosterone is not the same as treating male infertility. In fact, exogenous testosterone can reduce sperm production. That distinction should be clear before therapy is started.
Testosterone medications come in several formulations. FDA-approved testosterone products include topical gels, transdermal patches, buccal systems, injections, and oral formulations depending on the specific product. (U.S. Food and Drug Administration)
Different routes can involve different dosing schedules, absorption patterns, practical considerations, and potential side effects.
The most appropriate option depends on the man’s circumstances and the medications actually offered by the clinic.
Injections
Gels
Creams
Pellets
Oral testosterone
Patches
Compounded testosterone
For men with appropriately diagnosed hypogonadism, testosterone therapy can help address symptoms and physiological effects associated with testosterone deficiency.
The Endocrine Society recommends testosterone therapy in hypogonadal men to maintain secondary sex characteristics and address symptoms of testosterone deficiency. (Endocrine Society)
But the expected benefit should depend on the symptom being treated. A man should not be promised that TRT will automatically:
Restore youthful energy.
Cause substantial weight loss.
Build significant muscle without effort.
Improve every case of erectile dysfunction.
Eliminate depression.
Reverse aging.
Those claims go beyond what responsible TRT care should promise. The more useful conversation is about which symptoms are reasonably related to testosterone deficiency and whether those symptoms improve after appropriately prescribed therapy.
Sometimes testosterone deficiency and erectile dysfunction occur together.
But erectile dysfunction can have many causes, including vascular disease, diabetes, medications, neurologic conditions, psychological factors, and other health issues.
TRT should not be presented as a universal erectile dysfunction therapy.
If a man has confirmed testosterone deficiency and sexual symptoms associated with it, testosterone therapy may be part of the discussion.
If testosterone is normal or another cause appears more likely, a different evaluation may be needed.
Testosterone influences body composition, but TRT should not be marketed as a weight-loss or bodybuilding therapy.
Men with genuine testosterone deficiency may experience changes in lean mass or other body-composition measures with treatment, but response varies and therapy does not replace nutrition, physical activity, sleep, or appropriate weight management.
The Endocrine Society’s 2026 statement specifically notes that for men whose appropriately diagnosed hypogonadism is associated with overweight or obesity and no other identified cause, weight loss is typically the first-line approach. (Endocrine Society)
That is an important distinction for Brazos. TRT should be used because the man has an appropriate testosterone-related indication, not because testosterone is being sold as a shortcut for changing body composition.
A low testosterone result does not automatically mean you need testosterone therapy.
Brazos can help you understand your symptoms, testing, possible causes, fertility considerations, and whether TRT is appropriate for your individual situation.
TRT has potential benefits and potential risks. The answer depends on the individual, the indication, the medication, and appropriate monitoring. One area where public information has changed is cardiovascular risk. In 2025, the FDA removed boxed-warning language about an increased risk of major adverse cardiovascular events from testosterone-product labeling after reviewing the TRAVERSE trial. At the same time, the FDA required warnings about increased blood pressure across testosterone products based on ambulatory blood-pressure monitoring studies. (U.S. Food and Drug Administration) The FDA later updated testosterone information again in 2026 following further review of the evidence. (U.S. Food and Drug Administration) This means the page should avoid both extremes. We should not say TRT "causes heart attacks." We also should not claim that TRT has no cardiovascular considerations. The current evidence supports a more careful discussion of individual cardiovascular health, blood pressure, treatment indication, and monitoring.
The FDA's required labeling changes are particularly relevant here. Postmarketing ambulatory blood-pressure studies found an increase in blood pressure with testosterone products as a class, leading the FDA to require product labeling to include appropriate blood-pressure warnings.(U.S. Food and Drug Administration) That does not mean every man using TRT will develop hypertension. It does mean blood pressure belongs in the safety conversation. A man's cardiovascular history, current blood pressure, medications, and other risk factors should be considered as part of responsible testosterone care.
Testosterone therapy can increase hemoglobin and hematocrit. If hematocrit rises too much, the blood can become more concentrated, which is one reason laboratory monitoring is important. The American Urological Association recommends measuring hemoglobin and hematocrit before testosterone therapy and counseling men about the risk of polycythemia. (AUA University) This is one of the clearest examples of why TRT cannot simply be prescribed and then ignored. Treatment needs follow-up.
Men commonly ask whether testosterone causes prostate cancer. The relationship is more nuanced than older marketing or fear-based messaging often suggests. The Endocrine Society recommends appropriate prostate-risk assessment and monitoring for certain men being considered for testosterone therapy, with decisions individualized according to age, risk factors, and screening preferences. (Endocrine Society) The FDA also revised testosterone labeling in 2026 regarding prostate cancer and benign prostatic hyperplasia based on updated evidence. (U.S. Food and Drug Administration) The appropriate message for Brazos is therefore not: "TRT causes prostate cancer." And not: "TRT has nothing to do with prostate health." Instead: Prostate history and individual risk should be reviewed before and during testosterone therapy when clinically appropriate.
TRT is not a set-it-and-forget-it therapy. After treatment begins, monitoring may include reviewing symptoms, side effects, blood pressure, testosterone levels, hematocrit, prostate-related considerations when appropriate, and other health information. The exact monitoring plan depends on the man, therapy used, health history, and clinical circumstances.
The Endocrine Society recommends evaluating response and adverse effects after TRT is started. (Endocrine Society)
Monitoring has two purposes. First, determine whether the therapy is actually helping with the problem it was prescribed to address.
Second, identify adverse effects or health changes that may require adjustment, additional evaluation, or discontinuation.
Testosterone levels can decline as men age, but age alone does not establish hypogonadism. This is an area where clinical and regulatory guidance has evolved.
The Endocrine Society continues to emphasize that the diagnosis should be based on symptoms plus consistently low, accurately measured testosterone rather than age alone. Its July 2026 statement cautions that labels such as “age-related” hypogonadism can blur the distinction between a treatable disorder and normal aging. (Endocrine Society). FDA labeling also changed in 2026, so older web content about restrictions around age-related low testosterone may be outdated. (U.S. Food and Drug Administration) For Brazos, the safer and more useful position is:
Do not diagnose a man from his age. Evaluate the symptoms, confirm the testosterone findings, investigate contributing factors, and decide whether TRT is appropriate for the individual.
No. Hormone Optimization is the broader Brazos parent service.
It covers evaluation of hormone-related concerns and the process of determining whether any hormone therapy is appropriate.
TRT is much more specific.
It focuses on testosterone deficiency in men and the decision about whether testosterone replacement should be used.
TRT is a form of hormone replacement therapy, but the search intent is different from the HRT page on the Brazos website.
The Brazos HRT page focuses on women’s hormone replacement during perimenopause and menopause.
This page focuses specifically on testosterone deficiency and TRT in men.
Keeping those pages separate prevents the website from forcing two very different audiences into the same discussion.
Brazos Vitality & Precision Wellness provides testosterone evaluation for men from its location at 2004 FM 2004, Suite B, Richwood, TX 77531. The starting point is not simply: “How high can we get my testosterone?” A better set of questions is:
Do your symptoms fit testosterone deficiency?
Have low testosterone levels been confirmed appropriately?
Could something else be contributing?
Why might testosterone be low?
Are you planning to have children?
Are there health issues that affect TRT candidacy?
If therapy is appropriate, what approach makes sense?
How will response and safety be monitored?
That creates a more responsible foundation for testosterone therapy.
TRT stands for testosterone replacement therapy. It involves prescribing testosterone to men with appropriately diagnosed testosterone deficiency when replacement therapy is considered clinically appropriate.
Symptoms alone cannot diagnose testosterone deficiency. Current Endocrine Society guidance recommends compatible symptoms or signs plus consistently low testosterone concentrations measured accurately and confirmed with repeat testing. ( Endocrine Society )
The Endocrine Society recommends confirming suspected testosterone deficiency with repeated morning fasting testosterone measurements. Its 2026 statement describes at least two early-morning fasting measurements as part of appropriate diagnosis. ( Endocrine Society )
Testosterone levels are generally highest earlier in the day. Clinical guidance commonly recommends early-morning testing when evaluating suspected testosterone deficiency. ( Endocrine Society )
No. Fatigue can have many causes. Low energy may occur with testosterone deficiency, but it is not specific enough to diagnose it. Evaluation and appropriate laboratory testing are needed.
Testosterone therapy may improve sexual symptoms in some men with appropriately diagnosed testosterone deficiency. Low libido can also have other causes, so testosterone should not be assumed to be the explanation without evaluation.
Not every case of erectile dysfunction is caused by low testosterone. TRT may be relevant when testosterone deficiency is appropriately diagnosed, but erectile dysfunction can also be related to vascular, metabolic, neurologic, medication-related, psychological, and other causes.
External testosterone can suppress sperm production and can reduce fertility. Men who are trying to conceive or want to preserve future fertility should discuss that goal before starting testosterone therapy. ( Endocrine Society )
This requires careful discussion before therapy begins. The Endocrine Society recommends against starting testosterone therapy in men planning fertility in the near term. ( Endocrine Society )
The FDA required testosterone-product labeling to include warnings about increased blood pressure after ambulatory monitoring studies showed a class-wide increase. The clinical significance depends on the individual, but blood pressure should be considered during treatment. ( U.S. Food and Drug Administratio )
The TRAVERSE trial did not show a meaningful increase in major adverse cardiovascular events compared with placebo, which led the FDA to remove older boxed-warning language related to cardiovascular outcomes. TRT still requires appropriate cardiovascular and blood-pressure assessment. ( U.S. Food and Drug Administratio )
Current evidence does not support reducing the relationship to a simple cause-and-effect statement. Prostate history and risk may still affect evaluation and monitoring, and current guidelines recommend individualized prostate-risk discussion for appropriate men. ( Endocrine Society )
It can. Testosterone can increase red blood cell production, which is why baseline and follow-up hematocrit monitoring may be appropriate. AUA guidance recommends baseline hemoglobin and hematocrit before testosterone therapy.( AUA University )
TRT should not be used or marketed primarily as a weight-loss therapy. Men with testosterone deficiency may experience body-composition changes, but weight management involves many factors. In certain men with low testosterone associated with overweight or obesity, weight loss may be an important first-line approach. ( Endocrine Society )
Testosterone affects muscle tissue, but TRT is not a bodybuilding program. It should be prescribed for an appropriate medical indication rather than for performance enhancement.
Response varies according to the symptom being addressed, formulation, dose, and individual. Brazos should publish a specific response or follow-up timeline only after confirming its actual clinical protocol.
Not necessarily. Duration depends on the cause of testosterone deficiency, response to therapy, changes in health, risks, goals, and ongoing evaluation. TRT should be reassessed rather than assumed to be permanent for every man.
CLINIC CONFIRMATION REQUIRED: Insert Brazos's actual testosterone formulations and delivery methods once confirmed.
If low energy, changes in libido or sexual function, strength, body composition, or previous testosterone results have raised questions, start with an appropriate evaluation.
Brazos Vitality & Precision Wellness can help determine whether your symptoms and laboratory findings support testosterone deficiency, whether additional evaluation is needed, and whether TRT may be appropriate for you.
Brazos Vitality & Precision Wellness
2004 FM 2004, Suite B
Richwood, TX 77531
